WO2025229563 - METHODS OF TREATING INFLAMMATORY BOWEL DISEASE
National phase entry is expected:
Publication Number
WO/2025/229563
Publication Date
06.11.2025
International Application No.
PCT/IB2025/054518
International Filing Date
30.04.2025
Title **
[English]
METHODS OF TREATING INFLAMMATORY BOWEL DISEASE
[French]
MÉTHODES DE TRAITEMENT D'UNE MALADIE INTESTINALE INFLAMMATOIRE
Applicants **
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Inventors
BUIL-BRUNA, Núria
SCOTT, Robert A.
UINGS, Iain J.
BERGES, Alienor
Priority Data
63/642,243
03.05.2024
US
63/681,219
09.08.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2583 | |
| EPO | Filing, Examination, Granting | 15729 | |
| Japan | Filing, Examination, Granting | 2587 | |
| South Korea | Filing, Examination, Granting | 2984 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
31,023
Contact Us
Abstract[English]
The disclosure provides a method of treating inflammatory bowel disease in a human subject by the administration of certain anti-IL-18 antibodies. The disclosure also provides certain anti-IL-18 antibodies for use in the treatment of inflammatory bowel disease in a human subject.[French]
La divulgation concerne une méthode de traitement d'une maladie intestinale inflammatoire chez un sujet humain par l'administration de certains anticorps anti-IL-18. L'invention concerne également certains anticorps anti-IL-18 destinés à être utilisés dans le traitement d'une maladie intestinale inflammatoire chez un sujet humain.